ALLOGENEIC MESENCHYMAL PRECURSOR CELLS ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	4

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-005674-61-LV (EUCTR)	13/09/2013	13/09/2013	Mesenchymal Precursor Cells (MPCs) for treatment of rheumatoid arthritis	A double-blind, randomized, placebo-controlled, multi-center, dose escalation study of a single intr ...	Rheumatoid arthritis MedDRA version: 16.0;Level: LLT;Classification code 10003268;Term: Arthritis rh ...	Product Name: Allogeneic Mesenchymal Precursor Cells Other descriptive name: ALLOGENEIC MESENCHYMAL P ...	Mesoblast, Inc	NULL	Not Recruiting			Female: yes Male: yes	90		Serbia;Hungary;Estonia;Czech Republic;Belgium;Poland;Croatia;Latvia
2	EUCTR2012-005674-61-EE (EUCTR)	12/09/2013	02/09/2013	Mesenchymal Precursor Cells (MPCs) for treatment of rheumatoid arthritis	A double-blind, randomized, placebo-controlled, multi-center, dose escalation study of a single intr ...	Rheumatoid arthritis MedDRA version: 14.1;Level: LLT;Classification code 10003268;Term: Arthritis rh ...	Product Name: Allogeneic Mesenchymal Precursor Cells Other descriptive name: ALLOGENEIC MESENCHYMAL P ...	Mesoblast, Inc	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	Serbia;Hungary;Czech Republic;Estonia;Belgium;Poland;Croatia;Latvia
3	EUCTR2012-005674-61-BE (EUCTR)	11/09/2013	30/08/2013	Mesenchymal Precursor Cells (MPCs) for treatment of rheumatoid arthritis	A double-blind, randomized, placebo-controlled, multi-center, dose escalation study of a single intr ...	Rheumatoid arthritis MedDRA version: 14.1;Level: LLT;Classification code 10003268;Term: Arthritis rh ...	Product Name: Allogeneic Mesenchymal Precursor Cells Other descriptive name: ALLOGENEIC MESENCHYMAL P ...	Mesoblast, Inc	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	Serbia;Hungary;Estonia;Czech Republic;Poland;Belgium;Croatia;Latvia
4	NCT01851070 (ClinicalTrials.gov)	July 2013	19/4/2013	A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis a ...	A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intrave ...	Rheumatoid Arthritis	Drug: Allogeneic Mesenchymal Precursor Cells;Drug: Normal Saline	Mesoblast, Ltd.	PPD	Completed	18 Years	80 Years	All	48	Phase 2	United States;Australia

First Previous1Next Last